Provider perspectives on beta-lactam therapeutic drug monitoring programs in the critically ill: a protocol for a multicenter mixed-methods study.

Erin Frazee BarretoAndrew D RuleMohammad H AlshaerJason A RobertsMohd Hafiz Abdul AzizMarc H ScheetzKristin C MaraPaul J JannettoOgnjen GajicJohn C O'HoroKasey R Boehmer

Published in: Implementation science communications (2021)

NCT04755777 .

Keyphrases

primary care
randomized controlled trial
public health
study protocol
cross sectional
clinical trial
double blind
multidrug resistant